M’sia aims to be Hepatitis C treatment hub


Smooth ceremony: Khairy (third from right) at the signing of a memorandum of collaboration between MHTC and Pharmaniaga at the insigHT Virtual Conference 2021 in Kuala Lumpur. Also present are (from left) Dr Noor Hisham, Mohd Daud, Mustapa, Pharmaniaga Berhad group managing director Datuk Zulkarnain Md Eusope and Deputy Finance Minister Mohd Shahar Abdullah. — FAIHAN GHANI/The Star

KUALA LUMPUR: Malaysia is gearing up to be a regional Hepatitis C treatment hub by offering a combination treatment of ravidasvir and sofosbuvir at affordable rates, says Khairy Jamaluddin.

The Health Minister said Malaysia was able to offer the drug combination as a new medical tourism product after it became the first country to be given conditional approval to provide the treatment.

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Nation

CAAM confirms burst aircraft tyre incident at Sultan Abdul Halim Airport
New Perlis exco with just five members possible, says MB
Operations resume at Sultan Abdul Halim Airport
Streamlined Customs checks for departing travellers at KLIA T1 starting Jan 1
Ewon Benedick pays working visit to major solar plant
Warisan yet to decide if it will contest Lamag, Kinabatangan seats, says Shafie
Floods: Number of evacuees drops in Johor, Pahang; situation unchanged in Melaka
Investigation papers on Banting assault incident referred to AGC
M’sia opposes any move to relocate Palestinians to Somaliland, says PM
MBPP reviewing suitability of pet-friendly mall

Others Also Read